Transmineo

Startup

Transmineo is driven by the urgency to help solve the geographical inequality of access to orphan medicines in Europe. We use modern digital and information technologies to set up a smart - fit for the future environment service-model for commercializing orphan medicines.

With the MyOwnData platform we enable RWE generation to help adress the HTA evidence gap to support your orphan drug value proposition to payers. The MyOwnData platform is complemented by Keen Access Insights through which we provide strategic support and HTA services to help you address you market access challenges in Europe.

website